Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 1
2020 1
2021 3
2022 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Non-motor effects of deep brain stimulation in Parkinson's disease motor subtypes.
Jost ST, Konitsioti A, Loehrer PA, Ashkan K, Rizos A, Sauerbier A, Dos Santos Ghilardi MG, Rosenkranz F, Strobel L, Gronostay A, Barbe MT, Evans J, Visser-Vandewalle V, Nimsky C, Fink GR, Silverdale M, Cury RG, Fonoff ET, Antonini A, Chaudhuri KR, Timmermann L, Martinez-Martin P, Dafsari HS; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group. Jost ST, et al. Parkinsonism Relat Disord. 2023 Apr;109:105318. doi: 10.1016/j.parkreldis.2023.105318. Epub 2023 Feb 9. Parkinsonism Relat Disord. 2023. PMID: 36842866
INTRODUCTION: Deep brain stimulation (DBS) is a well-established treatment for patients with Parkinson's disease (PD) improving quality of life, motor, and non-motor symptoms. ...We hypothesized that patients with 'postural instability and gait difficulty' (P …
INTRODUCTION: Deep brain stimulation (DBS) is a well-established treatment for patients with Parkinson's disease (PD) i …
A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson's disease: results at the 36-month follow-up.
Jost ST, Sauerbier A, Visser-Vandewalle V, Ashkan K, Silverdale M, Evans J, Loehrer PA, Rizos A, Petry-Schmelzer JN, Reker P, Fink GR, Franklin J, Samuel M, Schnitzler A, Barbe MT, Antonini A, Martinez-Martin P, Timmermann L, Ray-Chaudhuri K, Dafsari HS; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group. Jost ST, et al. J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):687-694. doi: 10.1136/jnnp-2019-322614. Epub 2020 May 5. J Neurol Neurosurg Psychiatry. 2020. PMID: 32371534 Clinical Trial.
OBJECTIVE: To examine 36-month effects of bilateral subthalamic nucleus deep brain stimulation (STN-DBS) on non-motor symptoms (NMS) compared with standard-of-care medical treatment (MED) in Parkinson's disease (PD). METHODS: Here we report the 36-month follo …
OBJECTIVE: To examine 36-month effects of bilateral subthalamic nucleus deep brain stimulation (STN-DBS) on non-motor symptoms (NMS) compare …
The New Satisfaction with Life and Treatment Scale (SLTS-7) in Patients with Parkinson's Disease.
Sauerbier A, Bachon P, Ambrosio L, Loehrer PA, Rizos A, Jost ST, Gronostay A, Konitsioti A, Barbe MT, Fink GR, Ashkan K, Nimsky C, Visser-Vandewalle V, Chaudhuri KR, Timmermann L, Martinez-Martin P, Dafsari HS; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group. Sauerbier A, et al. J Parkinsons Dis. 2022;12(1):453-464. doi: 10.3233/JPD-212823. J Parkinsons Dis. 2022. PMID: 34719509
BACKGROUND: The satisfaction with life and, in particular, with treatment in Parkinson's disease (PD) is understudied. OBJECTIVE: To explore a new 7-item rating tool assessing satisfaction with life and treatment (SLTS-7) in PD. ...
BACKGROUND: The satisfaction with life and, in particular, with treatment in Parkinson's disease (PD) is understudied. …
Gender gap in deep brain stimulation for Parkinson's disease.
Jost ST, Strobel L, Rizos A, Loehrer PA, Ashkan K, Evans J, Rosenkranz F, Barbe MT, Fink GR, Franklin J, Sauerbier A, Nimsky C, Sattari A, Ray Chaudhuri K, Antonini A, Timmermann L, Martinez-Martin P, Silverdale M, Kalbe E, Visser-Vandewalle V, Dafsari HS; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group. Jost ST, et al. NPJ Parkinsons Dis. 2022 Apr 20;8(1):47. doi: 10.1038/s41531-022-00305-y. NPJ Parkinsons Dis. 2022. PMID: 35444187 Free PMC article.
Previous studies have shown less access to deep brain stimulation (DBS) for Parkinson's disease (PD) in women compared to men raising concerns about a potential gender gap resulting from nonclinical factors or gender differences in clinical efficacy for posto …
Previous studies have shown less access to deep brain stimulation (DBS) for Parkinson's disease (PD) in women compared …
Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease.
Jost ST, Visser-Vandewalle V, Rizos A, Loehrer PA, Silverdale M, Evans J, Samuel M, Petry-Schmelzer JN, Sauerbier A, Gronostay A, Barbe MT, Fink GR, Ashkan K, Antonini A, Martinez-Martin P, Chaudhuri KR, Timmermann L, Dafsari HS; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group. Jost ST, et al. NPJ Parkinsons Dis. 2021 Jun 8;7(1):48. doi: 10.1038/s41531-021-00174-x. NPJ Parkinsons Dis. 2021. PMID: 34103534 Free PMC article.
To identify predictors of 36-month follow-up quality of life (QoL) outcome after bilateral subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson's disease (PD). In this ongoing, prospective, multicenter international study (Cologne, Manches …
To identify predictors of 36-month follow-up quality of life (QoL) outcome after bilateral subthalamic nucleus deep brain stimulation (STN-D …
Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years: A Nonrandomized Controlled Trial.
Jost ST, Aloui S, Evans J, Ashkan K, Sauerbier A, Rizos A, Petry-Schmelzer JN, Gronostay A, Fink GR, Visser-Vandewalle V, Antonini A, Silverdale M, Timmermann L, Martinez-Martin P, Chaudhuri KR, Dafsari HS; International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group and EUROPAR. Jost ST, et al. JAMA Netw Open. 2024 Jan 2;7(1):e2352177. doi: 10.1001/jamanetworkopen.2023.52177. JAMA Netw Open. 2024. PMID: 38236600 Free PMC article. Clinical Trial.
IMPORTANCE: Deep brain stimulation of the subthalamic nucleus (STN-DBS) improves quality of life (QOL) in patients with advanced Parkinson disease (PD). However, controlled studies with more than 3 years of follow-up are lacking. ...EXPOSURE: Treatment for PD of STN …
IMPORTANCE: Deep brain stimulation of the subthalamic nucleus (STN-DBS) improves quality of life (QOL) in patients with advanced Parkinso …
Subthalamic Stimulation Improves Quality of Sleep in Parkinson Disease: A 36-Month Controlled Study.
Jost ST, Ray Chaudhuri K, Ashkan K, Loehrer PA, Silverdale M, Rizos A, Evans J, Petry-Schmelzer JN, Barbe MT, Sauerbier A, Fink GR, Visser-Vandewalle V, Antonini A, Martinez-Martin P, Timmermann L, Dafsari HS; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group. Jost ST, et al. J Parkinsons Dis. 2021;11(1):323-335. doi: 10.3233/JPD-202278. J Parkinsons Dis. 2021. PMID: 33074192 Clinical Trial.
BACKGROUND: Sleep disturbances and neuropsychiatric symptoms are some of the most common nonmotor symptoms in Parkinson's disease (PD). The effect of subthalamic stimulation (STN-DBS) on these symptoms beyond a short-term follow-up is unclear. ...METHODS: In …
BACKGROUND: Sleep disturbances and neuropsychiatric symptoms are some of the most common nonmotor symptoms in Parkinson's d …
EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
Dafsari HS, Martinez-Martin P, Rizos A, Trost M, Dos Santos Ghilardi MG, Reddy P, Sauerbier A, Petry-Schmelzer JN, Kramberger M, Borgemeester RWK, Barbe MT, Ashkan K, Silverdale M, Evans J, Odin P, Fonoff ET, Fink GR, Henriksen T, Ebersbach G, Pirtošek Z, Visser-Vandewalle V, Antonini A, Timmermann L, Ray Chaudhuri K; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group. Dafsari HS, et al. Mov Disord. 2019 Mar;34(3):353-365. doi: 10.1002/mds.27626. Epub 2019 Feb 4. Mov Disord. 2019. PMID: 30719763
OBJECTIVE: Real-life observational report of clinical efficacy of bilateral subthalamic stimulation (STN-DBS), apomorphine (APO), and intrajejunal levodopa infusion (IJLI) on quality of life, motor, and nonmotor symptoms (NMS) in Parkinson's disease (PD). MET …
OBJECTIVE: Real-life observational report of clinical efficacy of bilateral subthalamic stimulation (STN-DBS), apomorphine (APO), and intraj …
Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease.
Sauerbier A, Loehrer P, Jost ST, Heil S, Petry-Schmelzer JN, Herberg J, Bachon P, Aloui S, Gronostay A, Klingelhoefer L, Baldermann JC, Huys D, Nimsky C, Barbe MT, Fink GR, Martinez-Martin P, Ray Chaudhuri K, Visser-Vandewalle V, Timmermann L, Weintraub D, Dafsari HS; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group. Sauerbier A, et al. J Neurol Neurosurg Psychiatry. 2021 Dec;92(12):1313-1318. doi: 10.1136/jnnp-2021-326131. Epub 2021 Sep 11. J Neurol Neurosurg Psychiatry. 2021. PMID: 34510000 Free PMC article.
BACKGROUND: The effects of subthalamic stimulation (subthalamic nucleus-deep brain stimulation, STN-DBS) on impulsive and compulsive behaviours (ICB) in Parkinson's disease (PD) are understudied. OBJECTIVE: To investigate clinical predictors of STN-DBS effect …
BACKGROUND: The effects of subthalamic stimulation (subthalamic nucleus-deep brain stimulation, STN-DBS) on impulsive and compulsive behavio …
Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age.
Dafsari HS, Reker P, Stalinski L, Silverdale M, Rizos A, Ashkan K, Barbe MT, Fink GR, Evans J, Steffen J, Samuel M, Dembek TA, Visser-Vandewalle V, Antonini A, Ray-Chaudhuri K, Martinez-Martin P, Timmermann L; EUROPAR and the IPMDS (International Parkinson's and Movement Disorders Society) Non-Motor Parkinson's Disease Study Group. Dafsari HS, et al. Mov Disord. 2018 Jan;33(1):99-107. doi: 10.1002/mds.27222. Epub 2017 Nov 18. Mov Disord. 2018. PMID: 29150860
OBJECTIVE: The purpose of this study was to investigate how quality of life outcome after bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson's disease (PD) depends on age. METHODS: In this prospective, open-label, multicenter study …
OBJECTIVE: The purpose of this study was to investigate how quality of life outcome after bilateral subthalamic nucleus (STN) deep brain sti …
11 results